Small Cap Healthcare Company Bags Order From National Health Mission, Assam

Krsnaa Diagnostics Ltd. on Jun 28, 2023, informed the exchange that it has received the letter of acceptance from the National Health Mission, Assam for the establishment, operation and maintenance of laboratory diagnostic centres in Assam.

In the exchange filing, the company said, "In line with the intimation given by the Company dated 01st May, 2023 with regards to qualification of Company as a L1 Bidder for tender issued by National Health Mission, Assam ("the authority") for establishment, operation and maintenance of laboratory diagnostic centres for collection, transportation, analysis and reporting of laboratory samples from the Govt. Health Facilities in entire State of Assam on Public Private Partnership (PPP) basis, this is to inform you the Authority has issued a Letter of Acceptance to the Company."

Stock Outlook

The shares of Krsnaa Diagnostics last traded at Rs 567.30 apiece, down 1.54% from its previous close of Rs 576.20 apiece on BSE. The stock's 52-week high is Rs 609.15 apiece, recorded on Jun 12, 2023, and 52-low at Rs 354 apiece, recorded on Feb 28, 2023.

The stock has fallen 2.75% in the past 1 week, and 3.03% in 2 weeks, respectively. It jumped 12.70% in 1 week and 28.65% in 3 months, respectively. It gave 5.29% positive return in 1 year.

About - Krsnaa Diagnostics Ltd.

Krsnaa Diagnostics Ltd. is a small cap engaged in the business of providing diagnostic services in India. The company provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centres across India with an extensive network across non-metro and lower-tier cities and towns. It has a market capitalisation of Rs 1,781.19 Crore.